ACQUIRED · 2024
Who Acquired Elixir (Rite Aid PBM)?
MedImpact Healthcare Systems · $576.5M· 6.1× EBITDA
The acquisition
Elixir (Rite Aid PBM) was acquired by MedImpact Healthcare Systems in 2024 for $576.5M. The deal was priced at 6.1× EBITDA / 0.10× revenue.
Elixir (Rite Aid PBM) at time of acquisition
Revenue
$4650.0M
EBITDA
$95.0M
Deal value
$576.5M
EV / EBITDA
6.1×
Similar pharmacy acquisitions
- University Compounding Pharmacy · acquired by Fagron in 2026 · $41.5M
- Choice Specialty Pharmacy Group · acquired by Better Choice Company, Inc. in 2025 · $28.0M
- Horizon Infusions · acquired by Rubicon in 2025 · $130.0M
- KabaFusion · acquired by Nautic Partners in 2025 · $2.20B
- Soleo Health · acquired by Court Square Capital and WindRose Health in 2025 · $1.10B
Run a valuation for a similar pharmacy business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the pharmacy calculator →More on pharmacy valuations
- Value a medical practice
- Value a dental practice
- Value a veterinary practice
- Pharmacy valuation calculator· head-term variant
- Pharmacy median multiples· real-deal benchmarks
- How to value a pharmacy· long-form guide
Sourced from Press reporting and earnings releases. Full deal page.
Citation: ExitValue.ai. (2024). Elixir (Rite Aid PBM) acquired by MedImpact Healthcare Systems. https://exitvalue.ai/acquired/elixir-rite-aid-pbm